IL150349A0 - Rapid onset formulation - Google Patents

Rapid onset formulation

Info

Publication number
IL150349A0
IL150349A0 IL15034901A IL15034901A IL150349A0 IL 150349 A0 IL150349 A0 IL 150349A0 IL 15034901 A IL15034901 A IL 15034901A IL 15034901 A IL15034901 A IL 15034901A IL 150349 A0 IL150349 A0 IL 150349A0
Authority
IL
Israel
Prior art keywords
rapid onset
formulation
onset formulation
given
enterically
Prior art date
Application number
IL15034901A
Other languages
English (en)
Original Assignee
Duchesnay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42104724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150349(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Duchesnay Inc filed Critical Duchesnay Inc
Publication of IL150349A0 publication Critical patent/IL150349A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Seal Device For Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Power Steering Mechanism (AREA)
IL15034901A 2000-12-20 2001-06-21 Rapid onset formulation IL150349A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002350195A CA2350195C (en) 2000-12-20 2000-12-20 Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
PCT/CA2001/000951 WO2003000263A1 (en) 2000-12-20 2001-06-21 Rapid onset formulation
US09/885,051 US6340695B1 (en) 2000-12-20 2001-06-21 Rapid onset formulation

Publications (1)

Publication Number Publication Date
IL150349A0 true IL150349A0 (en) 2003-12-23

Family

ID=42104724

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15034901A IL150349A0 (en) 2000-12-20 2001-06-21 Rapid onset formulation

Country Status (34)

Country Link
US (1) US6340695B1 (pl)
EP (1) EP1397133B1 (pl)
JP (1) JP4242763B2 (pl)
KR (1) KR100527985B1 (pl)
CN (1) CN1229112C (pl)
AT (1) ATE307582T1 (pl)
AU (1) AU2001272243B2 (pl)
BE (1) BE1014929A4 (pl)
BR (1) BR0107371A (pl)
CA (1) CA2350195C (pl)
DE (2) DE10196426T1 (pl)
DK (2) DK1397133T3 (pl)
EG (1) EG24483A (pl)
ES (1) ES2251494T3 (pl)
FI (1) FI117961B (pl)
FR (1) FR2826277B1 (pl)
GB (1) GB2383751C (pl)
GR (1) GR1004371B (pl)
HU (1) HU227003B1 (pl)
IL (1) IL150349A0 (pl)
IS (1) IS2225B (pl)
IT (1) ITTO20020524A1 (pl)
LU (1) LU90934B1 (pl)
MC (1) MC200059A1 (pl)
MX (1) MXPA02006037A (pl)
MY (1) MY132786A (pl)
NL (1) NL1020895C2 (pl)
NO (1) NO332190B1 (pl)
PL (1) PL204507B1 (pl)
SE (1) SE526307C2 (pl)
TR (1) TR200201685T1 (pl)
UA (1) UA74807C2 (pl)
UY (1) UY27352A1 (pl)
WO (1) WO2003000263A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US8257746B2 (en) 2001-04-10 2012-09-04 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
US8012506B2 (en) * 2001-04-10 2011-09-06 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
ES2229876B1 (es) * 2001-06-26 2006-03-01 Duchesnay Inc. Formulacion de accion rapida.
CA2392486A1 (en) * 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
JP2004231520A (ja) * 2003-01-28 2004-08-19 Nichiko Pharmaceutical Co Ltd 保存安定性及び溶出速度に優れた医薬組成物
US20050004181A1 (en) * 2003-07-03 2005-01-06 Duchesnay Inc. Use of anti-emetic for pre and post operative care
CA103771S (en) 2003-07-22 2006-01-18 Duchesnay Inc Pharmaceutical dosage form
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
MX2007007836A (es) 2004-12-27 2007-08-20 Eisai R&D Man Co Ltd Metodo para estabilizar un farmaco anti-demencia.
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
CN101166543B (zh) * 2005-04-28 2014-07-16 卫材R&D管理有限公司 含抗痴呆药物的组合物
US20070277530A1 (en) * 2006-05-31 2007-12-06 Constantin Alexandru Dinu Inlet flow conditioner for gas turbine engine fuel nozzle
CN102108059B (zh) * 2010-09-03 2012-05-09 合肥工业大学 一种琥珀酸多西拉敏的合成方法
US8950188B2 (en) 2011-09-09 2015-02-10 General Electric Company Turning guide for combustion fuel nozzle in gas turbine and method to turn fuel flow entering combustion chamber
WO2013123569A1 (en) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
MX355912B (es) * 2012-02-22 2018-05-04 Duchesnay Inc Formulación de doxilamina y piridoxina y/o sus metabolitos o sales.
DK2851075T3 (da) 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
SG11201600122RA (en) 2013-07-22 2016-02-26 Duchesnay Inc Composition for the management of nausea and vomiting
CN103432126A (zh) * 2013-08-05 2013-12-11 北京阜康仁生物制药科技有限公司 一种治疗孕吐的药物组合物
US9526703B2 (en) 2014-08-29 2016-12-27 Duchesnay Inc. Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
EP3185856B1 (en) 2014-08-29 2018-05-23 Duchesnay Inc. Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
EP3337480A4 (en) 2015-08-17 2019-05-08 Aequus Pharmaceuticals Inc. TRANSDERMAL ADMINISTRATION OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
CN105510512B (zh) * 2016-01-25 2018-06-29 南京济群医药科技股份有限公司 一种琥珀酸多西拉敏有关物质的rt-hplc检测方法
RS61368B1 (sr) * 2018-09-27 2021-02-26 Inibsa Ginecologia S A Postupak za pripremu višejediničnog oralnog doznog oblika sa modifikovanim oslobađanjem doksilamin sukcinata i piridoksin hidrohlorida
CN114099450A (zh) * 2020-08-31 2022-03-01 长春海悦药业股份有限公司 一种比拉斯汀片及其制备方法
AU2021225255B1 (en) * 2021-09-03 2022-06-16 Patel, Mihir MR Compositions, kits, and methods to provide synergistic and/or additive effects from comprised ingredients for the prevention, treatment and management of nausea and vomiting.
CN118638044A (zh) * 2023-03-13 2024-09-13 南京济群医药科技股份有限公司 一种快速释放的琥珀酸多西拉敏组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085641A1 (en) * 1970-04-20 1971-12-31 Investigations Sci Pharm Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
CA2139896C (en) * 1995-01-10 2000-03-28 Don B. Mcdonah Use of antinauseant agent for terminally ill humans
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
WO2001019901A2 (en) * 1999-09-14 2001-03-22 Smithkline Beecham Corporation Process for making aqueous coated beadlets
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate

Also Published As

Publication number Publication date
HUP0301950A3 (en) 2005-06-28
DE10196426T1 (de) 2003-08-21
DK1397133T3 (da) 2006-02-27
WO2003000263A1 (en) 2003-01-03
EP1397133B1 (en) 2005-10-26
CN1229112C (zh) 2005-11-30
BE1014929A4 (fr) 2004-06-01
FI20021708A0 (fi) 2002-09-25
EP1397133A1 (en) 2004-03-17
GR1004371B (el) 2003-10-23
DE60114475D1 (de) 2005-12-01
DE60114475T2 (de) 2006-07-13
MC200059A1 (fr) 2003-01-30
SE0202061L (sv) 2003-01-28
MY132786A (en) 2007-10-31
PL204507B1 (pl) 2010-01-29
PL362763A1 (pl) 2004-11-02
AU2001272243B2 (en) 2004-02-05
BR0107371A (pt) 2003-06-10
NO20022982D0 (no) 2002-06-20
NL1020895A1 (nl) 2002-12-30
GB2383751A (en) 2003-07-09
IE20020488A1 (en) 2003-04-30
KR100527985B1 (ko) 2005-11-09
LU90934B1 (fr) 2002-12-23
ITTO20020524A1 (it) 2003-12-18
GB0213990D0 (en) 2002-07-31
CA2350195C (en) 2003-06-10
FI117961B (fi) 2007-05-15
MXPA02006037A (es) 2005-05-12
GR20020100280A (el) 2003-03-28
CA2350195A1 (en) 2001-08-11
IS2225B (is) 2007-04-15
NO332190B1 (no) 2012-07-23
NO20022982L (no) 2002-10-09
JP2004521146A (ja) 2004-07-15
CN1447694A (zh) 2003-10-08
ATE307582T1 (de) 2005-11-15
KR20030023612A (ko) 2003-03-19
FR2826277A1 (fr) 2002-12-27
FI20021708L (fi) 2002-12-22
SE526307C2 (sv) 2005-08-16
TR200201685T1 (tr) 2003-06-23
HK1052654A1 (en) 2003-09-26
JP4242763B2 (ja) 2009-03-25
HU227003B1 (en) 2010-04-28
IS6412A (is) 2002-12-22
ITTO20020524A0 (it) 2002-06-18
FR2826277B1 (fr) 2004-07-02
EG24483A (en) 2009-08-09
US6340695B1 (en) 2002-01-22
HUP0301950A2 (hu) 2003-11-28
NL1020895C2 (nl) 2003-03-13
DK176018B1 (da) 2005-12-05
GB2383751C (en) 2008-08-05
GB2383751B (en) 2005-02-09
ES2251494T3 (es) 2006-05-01
DK200200947A (da) 2003-01-03
UA74807C2 (en) 2006-02-15
UY27352A1 (es) 2002-09-30
SE0202061D0 (sv) 2002-07-03

Similar Documents

Publication Publication Date Title
GB2383751B (en) Rapid onset formulation
IL206830A (en) Use of an integrin-containing antagonist of the alpha 1 subunit - of the integrin to prepare a drug for the treatment of osteoporosis
HUP0105302A2 (hu) 2,3,4,5-Tetrahidro-1H-[1,4]benzodiazepin-3-hidroxámsavak mint mátrix metalloproteináz-inhibitorok, alkalmazásuk és eljárás az előállításukra
ZA200202521B (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds.
PL346764A1 (en) New oral formulation for 5-ht4
NO994822L (no) Immunotolerant protrombinkomplekspreparat
WO2002056745A3 (en) Method of treating parkinson's disease
AU6539000A (en) Composition and method for treating disease by increasing activated alpha2 macroglobulin in the blood and extravascular tissue
EP1213017A3 (en) Use of a 5-HT2C receptor agonist for the treatment of hot flushes
BG105204A (en) Salts of paroxetine
PL336315A1 (en) Derivatives of 5-aryl-3- (8-azabicyclo[3.2.1] oct-3-yl) 1,3,4- oxadiazol-2-(2h)-one, their production and therapeutic application_
AU2517199A (en) Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent
AU2422199A (en) Ustilipides, method for the production and the use thereof
杨启 et al. Geometric Precision of Datum Line in Shell Plate Expansion Methods
谷湘潜 et al. A new method to improve the precision of time difference
贺云 et al. Visiting a Doctor (Ⅷ) At the Optician's
Iftikhar " OH, THE LAND OF ZHONG HUA
EP1321146A3 (en) Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use
沈海铭 et al. Physiological Regulation of Calonyctinin Sweetpotato Development
ZA200102029B (en) Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed